Pertussis vaccine acellular with diphtheria and tetanus toxoids (Adacel) has been approved by the PBAC for use under the National Immunisation Program (NIP). The vaccine is restricted to active immunisation in adolescents aged at least 10 years but less than 18 years, as a booster after primary immunisation.
This is the first vaccine to be considered under new arrangements in which advice on funding vaccines has become the function of the PBAC. The NIP, under which the Department of Health and Ageing provides free vaccines to Australians, will replace the Australian Standard Vaccination Schedule.
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.